CRISPR Therapeutics
Dr. Simeon George has served on our Board of Directors since April 2015. Simeon currently serves as a Partner at SR One, where he has been employed since 2007. In addition, Dr. George previously served as a director on the boards of the following biotechnology companies: Semprus BioSciences (acquired by Teleflex in June 2012), HTG Molecular Diagnostics and Genocea Biosciences. He also served as a consultant at Bain & Company from October 2006 to August 2007. Simeon received an M.D. from the University of Pennsylvania School of Medicine, an M.B.A. as a Mayer Scholar from the Wharton School of the University of Pennsylvania and a B.A. in Neuroscience from Johns Hopkins University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
CRISPR Therapeutics
11 followers
CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9